
zzso are central zzso of zzso at sites of vascular injury, but they also mediate zzso zzso zzso zzso stimulate zzso formation in response to zzso of an zzso plaque or zzso cell zzso promoting zzso zzso They also interact with zzso cells and zzso to promote zzso which contributes to zzso Multiple pathways contribute to zzso zzso and current oral zzso therapy with aspirin and a zzso zzso zzso zzso zzso zzso target the zzso zzso and zzso zzso zzso Both can diminish zzso by other factors, but the extent of their effects depends upon the zzso zzso strength, and zzso zzso zzso Although these agents have demonstrated significant clinical benefit, residual morbidity and mortality remain zzso Neither agent is effective in zzso zzso the most potent zzso zzso This lack of comprehensive zzso of zzso function allows continued zzso formation and exposes patients to risk for zzso zzso zzso Moreover, bleeding risk is a substantial limitation of zzso therapy, because these agents target zzso zzso pathways critical for both protective zzso and zzso zzso Novel zzso therapies that provide more complete zzso of zzso zzso without increasing bleeding risk could considerably decrease residual risk for zzso zzso zzso of the zzso zzso zzso zzso zzso zzso zzso by zzso is a novel, emerging approach to achieve more comprehensive zzso of zzso zzso when used in combination with current oral zzso zzso zzso zzso is not expected to increase bleeding risk, as this zzso does not interfere with zzso 

